Monday, May 20, 2024

GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line

Must read




The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article